D-Index & Metrics

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Chemistry D-index 41 Citations 6,737 234 World Ranking 14435 National Ranking 2001

Overview

What is he best known for?

The fields of study he is best known for:

  • Enzyme
  • DNA
  • Organic chemistry

His primary areas of investigation include Stereochemistry, Reverse transcriptase, Nucleoside Reverse Transcriptase Inhibitor, Drug discovery and Computational biology. He combines subjects such as Structure–activity relationship, Chemical synthesis and Enzyme inhibitor with his study of Stereochemistry. His research integrates issues of Nevirapine and Biological activity in his study of Reverse transcriptase.

His work carried out in the field of Nucleoside Reverse Transcriptase Inhibitor brings together such families of science as Etravirine, Discovery and development of non-nucleoside reverse-transcriptase inhibitors, Virology, Diarylpyrimidines and Piperidine. His studies deal with areas such as Click chemistry and Pharmacology as well as Drug discovery. His Computational biology research includes elements of Pharmacophore, Acquired immunodeficiency syndrome and Drug.

His most cited work include:

  • Anti-HIV Drug Discovery and Development: Current Innovations and Future Trends (157 citations)
  • Current drug research on PEGylation with small molecular agents (143 citations)
  • HIV-1 NNRTIs: structural diversity, pharmacophore similarity, and implications for drug design. (143 citations)

What are the main themes of his work throughout his whole career to date?

The scientist’s investigation covers issues in Stereochemistry, Reverse transcriptase, Combinatorial chemistry, Virology and Potency. His Stereochemistry research incorporates elements of EC50, Design synthesis and Structure–activity relationship. His Reverse transcriptase study combines topics in areas such as Nevirapine and Cytotoxicity.

His Nevirapine research is multidisciplinary, incorporating elements of Delavirdine and Efavirenz. The various areas that Peng Zhan examines in his Combinatorial chemistry study include Binding site and Drug discovery. As part of the same scientific family, Peng Zhan usually focuses on Potency, concentrating on Pharmacology and intersecting with Drug resistance.

He most often published in these fields:

  • Stereochemistry (39.92%)
  • Reverse transcriptase (29.03%)
  • Combinatorial chemistry (20.56%)

What were the highlights of his more recent work (between 2019-2021)?

  • Reverse transcriptase (29.03%)
  • Potency (14.92%)
  • Virology (14.92%)

In recent papers he was focusing on the following fields of study:

Peng Zhan mostly deals with Reverse transcriptase, Potency, Virology, Etravirine and Stereochemistry. The Reverse transcriptase study combines topics in areas such as Biochemistry, Strain, Design synthesis, Molecular biology and Drug. He has included themes like Pharmacokinetics, Pharmacology, Rational design, Enzyme and Diarylpyrimidines in his Potency study.

His Etravirine study combines topics from a wide range of disciplines, such as Nevirapine, Rilpivirine and Structure–activity relationship. His work in Structure–activity relationship addresses issues such as Nitrile, which are connected to fields such as Combinatorial chemistry. He studies Stereochemistry, namely Pyrimidine.

Between 2019 and 2021, his most popular works were:

  • Inhibitors of SARS-CoV-2 Entry: Current and Future Opportunities. (51 citations)
  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) membrane (M) protein inhibits type I and III interferon production by targeting RIG-I/MDA-5 signaling. (25 citations)
  • New techniques and strategies in drug discovery (21 citations)

In his most recent research, the most cited papers focused on:

  • Enzyme
  • DNA
  • Organic chemistry

His scientific interests lie mostly in Drug discovery, Mechanism of action, Potency, Severe acute respiratory syndrome coronavirus 2 and Virology. Peng Zhan interconnects Virtual screening, Drug, Drug repositioning, Prodrug and Computational biology in the investigation of issues within Drug discovery. His study in Potency is interdisciplinary in nature, drawing from both EC50, Pharmacokinetics and Pyrimidine.

His Pharmacokinetics study incorporates themes from Thiophene and Piperidine, Stereochemistry. In most of his Piperidine studies, his work intersects topics such as Reverse transcriptase. His studies examine the connections between Drug resistance and genetics, as well as such issues in Nitrile, with regards to Combinatorial chemistry and Etravirine.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Peng Zhan

Christophe Pannecouque

Christophe Pannecouque

Rega Institute for Medical Research

Publications: 58

Erik De Clercq

Erik De Clercq

Rega Institute for Medical Research

Publications: 48

Takayoshi Suzuki

Takayoshi Suzuki

Osaka University

Publications: 24

Nicholas A. Meanwell

Nicholas A. Meanwell

Bristol-Myers Squibb (Germany)

Publications: 15

Jan Balzarini

Jan Balzarini

KU Leuven

Publications: 13

Xinyong Liu

Xinyong Liu

Shandong University

Publications: 10

Yong-Tang Zheng

Yong-Tang Zheng

Kunming Institute of Zoology

Publications: 10

Lei Wang

Lei Wang

University of California, San Francisco

Publications: 10

Giovanni Maga

Giovanni Maga

National Academies of Sciences, Engineering, and Medicine

Publications: 9

Hong-Min Liu

Hong-Min Liu

Zhengzhou University

Publications: 9

Eddy Arnold

Eddy Arnold

Rutgers, The State University of New Jersey

Publications: 9

William L. Jorgensen

William L. Jorgensen

Yale University

Publications: 9

Dominique Schols

Dominique Schols

KU Leuven

Publications: 9

Wim Dehaen

Wim Dehaen

KU Leuven

Publications: 8

Stefano Alcaro

Stefano Alcaro

Magna Graecia University

Publications: 7

Alireza Foroumadi

Alireza Foroumadi

Tehran University of Medical Sciences

Publications: 7

Something went wrong. Please try again later.